P3.12-11 Association of the Lung Immune Prognostic Index (LIPI) With Outcomes for Immune Checkpoint Inhibitors in Diffuse SCLC Patients
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1834
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV